Ann Arbor Stage IIA Hodgkin Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08870 | Brentuximab vedotin | 1 / 2 | Active Not Recruiting | 1 |
| DB00851 | Dacarbazine | 1 / 2 | Active Not Recruiting | 1 |
| DB00997 | Doxorubicin | 1 / 2 | Active Not Recruiting | 1 |
| DB03366 | Imidazole | 1 / 2 | Active Not Recruiting | 1 |
| DB00570 | Vinblastine | 1 / 2 | Active Not Recruiting | 1 |
| DB00290 | Bleomycin | 2 | Active Not Recruiting | 1 |
| DB08870 | Brentuximab vedotin | 2 | Active Not Recruiting | 3 |
| DB00851 | Dacarbazine | 2 | Active Not Recruiting | 2 |
| DB00694 | Daunorubicin | 2 | Active Not Recruiting | 2 |
| DB00997 | Doxorubicin | 2 | Active Not Recruiting | 2 |
| DB03366 | Imidazole | 2 | Active Not Recruiting | 2 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 3 |
| DB00570 | Vinblastine | 2 | Active Not Recruiting | 2 |